Annual FCF
-$1.52 M
+$220.00 K+12.63%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual free cash flow is -$1.52 million, with the most recent change of +$220.00 thousand (+12.63%) on December 31, 2023.
- During the last 3 years, MACK annual FCF has risen by +$3.10 million (+67.09%).
Performance
MACK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$1.31 M
-$1.02 M-345.42%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly free cash flow is -$1.31 million, with the most recent change of -$1.02 million (-345.42%) on March 1, 2024.
- Over the past year, MACK quarterly FCF has dropped by -$1.11 million (-547.29%).
Performance
MACK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$2.48 M
-$958.00 K-62.94%
March 1, 2024
Summary
- As of February 10, 2025, MACK TTM free cash flow is -$2.48 million, with the most recent change of -$958.00 thousand (-62.94%) on March 1, 2024.
- Over the past year, MACK TTM FCF has dropped by -$1.07 million (-75.64%).
Performance
MACK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MACK Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.6% | -547.3% | -75.6% |
| 3 y3 years | +67.1% | -547.3% | -75.6% |
| 5 y5 years | +97.7% | -547.3% | -75.6% |
MACK Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +598.2% | +14.5% | +610.3% | at low | +1737.0% | at low |
| 5 y | 5-year | +598.2% | +1961.0% | -228.9% | +100.9% | +1737.0% | +1164.8% |
| alltime | all time | -110.9% | >+9999.0% | -102.2% | +4864.0% | +1737.0% | +6871.0% |
Merrimack Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$1.31 M(+345.4%) | -$2.48 M(+62.9%) |
| Dec 2023 | -$1.52 M(-12.6%) | -$295.00 K(+45.3%) | -$1.52 M(+7.8%) |
| Sep 2023 | - | -$203.00 K(-69.6%) | -$1.41 M(-4.1%) |
| Jun 2023 | - | -$668.00 K(+87.6%) | -$1.47 M(-15.5%) |
| Mar 2023 | - | -$356.00 K(+92.4%) | -$1.74 M(+0.1%) |
| Dec 2022 | -$1.74 M(+699.1%) | -$185.00 K(-29.9%) | -$1.74 M(-8.9%) |
| Sep 2022 | - | -$264.00 K(-71.9%) | -$1.91 M(-8.6%) |
| Jun 2022 | - | -$939.00 K(+165.3%) | -$2.09 M(+1450.4%) |
| Mar 2022 | - | -$354.00 K(-0.3%) | -$135.00 K(-38.1%) |
| Dec 2021 | -$218.00 K(-95.3%) | -$355.00 K(-20.2%) | -$218.00 K(-86.7%) |
| Sep 2021 | - | -$445.00 K(-143.7%) | -$1.64 M(+54.8%) |
| Jun 2021 | - | $1.02 M(-333.2%) | -$1.06 M(-73.9%) |
| Mar 2021 | - | -$437.00 K(-75.4%) | -$4.06 M(-12.3%) |
| Dec 2020 | -$4.63 M(-85.3%) | -$1.78 M(-1415.6%) | -$4.63 M(-15.7%) |
| Sep 2020 | - | $135.00 K(-106.8%) | -$5.49 M(-37.8%) |
| Jun 2020 | - | -$1.98 M(+96.9%) | -$8.83 M(-52.8%) |
| Mar 2020 | - | -$1.00 M(-61.9%) | -$18.72 M(-40.3%) |
| Dec 2019 | -$31.37 M(-52.3%) | -$2.64 M(-17.6%) | -$31.37 M(-34.1%) |
| Sep 2019 | - | -$3.20 M(-73.0%) | -$47.62 M(-17.2%) |
| Jun 2019 | - | -$11.87 M(-13.0%) | -$57.53 M(-7.2%) |
| Mar 2019 | - | -$13.65 M(-27.7%) | -$62.00 M(-5.6%) |
| Dec 2018 | -$65.71 M(-48.2%) | -$18.89 M(+44.1%) | -$65.71 M(-8.5%) |
| Sep 2018 | - | -$13.11 M(-19.8%) | -$71.79 M(-15.3%) |
| Jun 2018 | - | -$16.34 M(-5.8%) | -$84.75 M(-36.6%) |
| Mar 2018 | - | -$17.36 M(-30.5%) | -$133.63 M(+5.5%) |
| Dec 2017 | -$126.73 M(-26.7%) | -$24.98 M(-4.2%) | -$126.73 M(-4.3%) |
| Sep 2017 | - | -$26.08 M(-60.0%) | -$132.42 M(-6.8%) |
| Jun 2017 | - | -$65.23 M(+524.4%) | -$142.08 M(+10.5%) |
| Mar 2017 | - | -$10.45 M(-65.9%) | -$128.57 M(-25.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$172.88 M(+47.4%) | -$30.67 M(-14.2%) | -$172.88 M(+15.8%) |
| Sep 2016 | - | -$35.74 M(-30.9%) | -$149.29 M(-6.7%) |
| Jun 2016 | - | -$51.72 M(-5.5%) | -$159.97 M(+17.9%) |
| Mar 2016 | - | -$54.75 M(+673.0%) | -$135.73 M(+15.8%) |
| Dec 2015 | -$117.26 M(+187.1%) | -$7.08 M(-84.7%) | -$117.26 M(-18.1%) |
| Sep 2015 | - | -$46.41 M(+68.9%) | -$143.18 M(+282.8%) |
| Jun 2015 | - | -$27.48 M(-24.3%) | -$37.40 M(-15.6%) |
| Mar 2015 | - | -$36.28 M(+9.9%) | -$44.30 M(+8.5%) |
| Dec 2014 | -$40.84 M(-61.1%) | -$33.01 M(-155.6%) | -$40.84 M(+13.3%) |
| Sep 2014 | - | $59.37 M(-272.7%) | -$36.06 M(-70.8%) |
| Jun 2014 | - | -$34.38 M(+4.7%) | -$123.50 M(+8.0%) |
| Mar 2014 | - | -$32.83 M(+16.3%) | -$114.31 M(+8.8%) |
| Dec 2013 | -$105.03 M(+26.5%) | -$28.22 M(+0.5%) | -$105.03 M(+7.2%) |
| Sep 2013 | - | -$28.08 M(+11.5%) | -$98.01 M(+8.4%) |
| Jun 2013 | - | -$25.18 M(+6.9%) | -$90.41 M(+4.1%) |
| Mar 2013 | - | -$23.55 M(+11.1%) | -$86.83 M(+4.6%) |
| Dec 2012 | -$83.00 M(+46.7%) | -$21.20 M(+3.5%) | -$83.00 M(+19.4%) |
| Sep 2012 | - | -$20.47 M(-5.2%) | -$69.55 M(+5.8%) |
| Jun 2012 | - | -$21.60 M(+9.5%) | -$65.73 M(-0.1%) |
| Mar 2012 | - | -$19.73 M(+154.9%) | -$65.79 M(+16.3%) |
| Dec 2011 | -$56.57 M(+80.2%) | -$7.74 M(-53.5%) | -$56.57 M(+2.2%) |
| Sep 2011 | - | -$16.65 M(-23.2%) | -$55.34 M(+47.7%) |
| Jun 2011 | - | -$21.67 M(+106.3%) | -$37.46 M(+36.2%) |
| Mar 2011 | - | -$10.51 M(+61.3%) | -$27.51 M(-12.4%) |
| Dec 2010 | -$31.39 M(-324.0%) | -$6.51 M(-631.2%) | -$31.39 M(+26.2%) |
| Sep 2010 | - | $1.23 M(-110.5%) | -$24.88 M(-4.7%) |
| Jun 2010 | - | -$11.71 M(-18.6%) | -$26.11 M(+81.4%) |
| Mar 2010 | - | -$14.39 M | -$14.39 M |
| Dec 2009 | $14.02 M | - | - |
FAQ
- What is Merrimack Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual FCF year-on-year change?
- What is Merrimack Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly FCF year-on-year change?
- What is Merrimack Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals TTM FCF year-on-year change?
What is Merrimack Pharmaceuticals annual free cash flow?
The current annual FCF of MACK is -$1.52 M
What is the all time high annual FCF for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual free cash flow is $14.02 M
What is Merrimack Pharmaceuticals annual FCF year-on-year change?
Over the past year, MACK annual free cash flow has changed by +$220.00 K (+12.63%)
What is Merrimack Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of MACK is -$1.31 M
What is the all time high quarterly FCF for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly free cash flow is $59.37 M
What is Merrimack Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, MACK quarterly free cash flow has changed by -$1.11 M (-547.29%)
What is Merrimack Pharmaceuticals TTM free cash flow?
The current TTM FCF of MACK is -$2.48 M
What is the all time high TTM FCF for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high TTM free cash flow is -$135.00 K
What is Merrimack Pharmaceuticals TTM FCF year-on-year change?
Over the past year, MACK TTM free cash flow has changed by -$1.07 M (-75.64%)